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Mutants of the pig kidney cell line. LLC-PK,, affected in CAMP metabolism, were examined for CAMP- 
dependent protein kinase (CAMP-PK) activity and for CAMP-mediated induction of urokinase-type plasmi- 
nogen activator (uPA). The FIB4 and FIB6 mutant cell lines possessed about 10% parental levels of CAMP- 
PK activity and concomitantly reduced uPA production (10-20s parental) in response to calcitonin. fors- 
kolin and 8-bromo CAMP. The FIBl, FIB2 and FIB5 mutant cell lines had about 70% parental levels of 
CAMP-PK and the synthesis of uPA was 40-60s parental. Thus, CAMP-mediated induction of uPA showed 
a dependence on the absolute levels of CAMP-PK. However, uPA synthesis in response to phorbol- 12-myr- 
istate- 13-acetate by all of the mutants was similar to parental, which indicates that enzyme induction medi- 
ated by phorbol esters does not involve CAMP or CAMP-PK. 
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1. INTRODUCTION 
All available evidence [l-3] suggests that the 
profound effects of adenosine 3 ’ ,5 ’ -mono- 
phosphate (CAMP) on cellular processes are ex- 
erted through phosphorylation of a variety of 
specific proteins, mediated by CAMP-dependent 
protien kinase (CAMP-PK) [4]. Among these ef- 
fects include specific induction of a number of en- 
zymes, including ornithine decarboxylase in 
glioma and neuroblastoma cells [5], hepatic 
tyrosine aminotransferase [6], CAMP phospho- 
diesterase in C-6 glioma cells [7], alkaline 
phosphatase in mouse L-cells [8], hepatic 
phosphoenofpyruvate carboxykinase [9], and 
urokinase-type plasminogen activator (uPA) in 
LLC-PKi cells [ 10,111. 
Here, the isolation of LLC-PKi mutant cell lines 
defective in CAMP metabolism is described. These 
were characterized in terms of CAMP-PK activity, 
and used to address the question of the role of the 
CAMP-PK in uPA induction. A direct correlation 
between CAMP-PK levels and uPA inducibility by 
CAMP effecters was observed. Significantly, the 
induction of uPA by phorbol esters [12,13] was 
unaffected in all of the mutants, indicating that 
CAMP and CAMP-PK are not involved in the in- 
duction of uPA by phorbol esters. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Pig epithelial cells, LLC-PKi [14] and mutants 
were cultured in plastic petri dishes in Dulbecco’s 
modified Eagle’s medium (DMEM, Gibco, Grand 
Island, NY) supplemented with 10% (v/v) fetal 
calf serum at 37°C. For hormonal treatments or 
addition of drugs, monolayer cultures were washed 
with serum-free DMEM and then incubated in 
serum-free DMEM containing the appropriate 
hormone or drug. Forskolin (Calbiochem) and 
isobutylmethylxanthine (IBMX, Sigma) were 
stored at -20°C as stocks of 10 and 25 mM solu- 
tions, respectively, in absolute ethanol, and ap- 
propriately diluted into media. 
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2.2. Enzyme assays 
The catalytic activity of CAMP-PK was assayed 
using the synthetic peptide Leu-Arg-Arg-Ala-Ser- 
Ala-Gly (Kemptide, Bachem), essentially as in 
[ 15,161. Protein kinase activity is expressed as units 
per mg protein (1 unit kinase activity is defined as 
the amount of enzyme that catalyzes the transfer 
of 1 nmol phosphate from ATP to the peptide per 
min). CAMP-PK regulatory subunit activity was 
quantitated using the Millipore filtration CAMP 
binding assay [ 171. Plasminogen activator activity 
was determined by measuring the plasminogen- 
dependent hydrolysis of the synthetic peptide 
S-225 1 (D-Val-Leu-Lys-p-nitroanilide, Bachem) 
and the activities are expressed in Ploug Units per 
mg cellular protein using purified urokinase (EC 
3.4.4.a, Calbiochem) as standard. Media to be 
assayed were serially diluted to constant specific 
activity. Human plasminogen was purified as in 
[ 18,191. Protein concentrations were measured ac- 
cording to Bradford [20] with bovine serum 
albumin as standard. Materials and chemicals were 
from standard sources as described [21]. 
Cell extracts were prepared in 20 mM 2-(N- 
morpholino)ethanesulphonate-NaOH, pH 6.8, 
containing 150 mM NaCl, 1 mM EDTA, and 0.2% 
(v/v) Triton X-100. For the CAMP binding assay 
the Triton X-100 was omitted. 
3. RESULTS 
3.1. Isolation of ‘CAMP resistant’ cell lines 
It was decided to generate mutant cell lines af- 
fected in CAMP metabolism using the 
phosphodiesterase (PDE) inhibitor IBMX [22] 
together with the adenylate cyclase (AC) activator 
forskolin [23]. Each had been shown in 
preliminary experiments to be cytotoxic. The com- 
bined use of these two reagents, elevating in- 
tracellular CAMP levels via stimulation of AC and 
by inhibition of PDE, was expected to bias the 
resistant cell population in favour of mutants af- 
fected at a point in CAMP metabolism distal to 
CAMP synthesis and degradation, such as CAMP- 
PK. Towards this end, LLC-PKr cells were seeded 
at 106/10 cm dish in DMEM containing 0.5 mM 
IBMX and 50pM forskolin. Cells were grown for 
3 weeks, passaged, grown for a further 3 weeks, 
and passaged and seeded into the same medium, 
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except that the IBMX concentration was raised to 
1 mM on the final seeding. Colonies began to form 
after a further 3 weeks and clonal cell lines (the 
FIB cell lines) derived. 
The clonal cell lines were removed from selective 
media and maintained in DMEM. After 8 weeks, 
the FIB cell lines were returned to selective media 
to ascertain whether the resistance phenotype had 
reverted in the absence of selection. No significant 
reduction in cell viability was observed, and the 
basis for resistance of all cell lines was assumed to 
be genetic. 
3.2. CAMP-PK of mutants 
The CAMP-PK levels of cell extracts from five of 
the isolated mutant cell lines were assayed (table 
1). Two distinct classes of mutants appeared. 
FIBl, FIB2 and FIB5 exhibited approx. 70% 
parental CAMP-PK activity, whereas FIB4 and 
FIB6 had very low CAMP-PK activity (<0.4 
U/mg). In contrast to having altered CAMP-PK 
catalytic activities, all the variant cell lines tested 
appeared to be largely comparable to parental in 
terms of CAMP-binding (regulatory subunit) ac- 
tivities (table 1). 
3.3. UPA induction in mutants 
As the five mutant cell lines represented iffer- 
ing phenotypes with respect to CAMP-PK, it was 
possible to use them to investigate the link between 
CAMP-PK and uPA induction. Salmon calcitonin, 
forskolin and the CAMP analogue 8-bromo CAMP 
(BrcAMP) can all be used to stimulate uPA induc- 
tion in LLC-PKi cells [lo, 111, as can 
phorbol-12-myristate-13-acetate (PMA) 1241, 
which is believed to induce uPA via a different but 
convergent pathway utilising the C-kinase ([24] 
and see below). Cells were induced for 8 h with 
hormonal effecters in DMEM lacking serum, prior 
to assay of uPA levels in the culture media (table 
2). 
Mutant cell lines FIBl, FIB2 and ‘FIBS were 
similar in that each produced levels of uPA in 
response to calcitonin 40-60% of parental. Iden- 
tical results were obtained with the polypeptide 
hormones vasopressin and human calcitonin (not 
shown). FIB1 responded similarly to forskolin 
(60% parental response) whereas FIB2 and FIB5 
responded to a lesser extent (about 30% parental). 
The FIB4 and FIB6 lines appeared similar in that 
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Table 1 
CAMP-PK levels and CAMP-binding activities in extracts 
from LLC-PK, mutant cell lines 
Cell line CAMP-PK activity CAMP-binding 
(units/mg) activity 
([3H]cAMP/mg) 
LLC-PKI 3.03 f 0.35 8.00 * 0.28 
FIB1 2.11 + 0.11 ND 
FIB2 2.00 + 0.20 7.07 f 0.08 
FIB4 0.41 f 0.05 5.86 + 0.05 
FIB5 2.10 f 0.19 5.62 f 0.10 
FIB6 0.39 * 0.07 7.26 ? 0.23 
ND, not determined; activities are expressed * SE of the 
mean 
they displayed about lo& parental uPA produc- 
tion in response to calcitonin and forskolin. These 
cells were studied in more detail, and the time 
course of uPA production was examined in 
response to calcitonin and to BrcAMP (which 
stimulates CAMP-PK directly). The results (fig. 1) 
supported the above findings of severely reduced 
uPA induction. The responses of all FIB mutants 
to PMA were similar and comparable to parental 
(table 2, fig.1). 
4. DISCUSSION 
Our results support the concept of the direct 
relationship between CAMP-PK levels and induc- 
tion of the enzyme uPA in LLC-PKI cells. 
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Fig. 1. Time course of uPA production in response to the 
inducers 30 nM salmon calcitonin (a), 1 mM BrcAMP 
(b) and 160 nM PMA (c) in LLC-PKl cells and mutants. 
(&--A) LLC-PKl, (o----o) FIB4, (H) FIB6, 
(v--v) control cells with no addition. Measurements 
were performed as in the legend to table 2, with 
duplicate plates sampled at the time intervals indicated. 
CAMP-PK levels, and their response to CAMP- 
mediated hormonal stimulation in terms of uPA 
production is about 40-60% parental. The pivotal 
role of CAMP-PK in uPA induction by agents 
stimulating the CAMP cascade is clearly 
demonstrated. As the mutant cell lines possessed 
levels of R subunit activity comparable to parental 
(table l), it can be concluded that it is the CAMP- 
PK catalytic activity (C subunit) that directly 
mediates uPA induction. 
Table 2 
uPA induction in mutant cell lines of LLC-PKl 
Cell line uPA activity (U/mg) 
- SCT FSK PMA 
LLC-PKl 0.26 f 0.0430.8 rt 2.3 22.3 2 1.2 4.9 + 0.6 
FIB1 0.19 f 0.02 13.4 k 1.1 14.2 f 3.9 5.2 f 2.2 
FIB2 0.10 f 0.05 16.4 + 5.2 6.2 f 0.7 4.4 f 0.8 
FIB4 0.30 -+ 0.17 3.5 + 0.5 2.4 + 0.5 5.1 + 0.4 
FIB5 0.31 f 0.12 15.5 + 4.5 6.2 + 0.3 4.9 f 0.7 
FIB6 0.46 + 0.19 0.55 f 0.1 2.0 f 0.3 4.4 f 0.1 
Cells were grown to confluency in DMEM, washed four times, 
treated with reagents for 8 h in serum-free DMEM (0.5 mg/ml 
bovine serum albumin) and the conditioned medium sampled and 
assayed. SCT, salmon calcitonin (30 nM); FSK, forskolin (100 
rM); PMA (160 nM) 
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Through the examination of mutants affected in 
CAMP-PK activity, it appears that the relative 
amount of CAMP-PK activity determines the ex- 
tent of enzyme induction. The mutants FIB4 and 
FIB6 provide the clearest evidence. They possess 
about 10% of parental levels of CAMP-PK 
catalytic-subunit (C-subunit) activity and also are 
concomitantly severely reduced in uPA production 
in response to CAMP-mediated stimuli (calcitonin, 
forskolin, and BrcAMP). Similarly, FIBl, FIB2 
and FIB5 appear to have about 70% of normal 
basic mechanism is likely to be similar in both, 
however: activation of kinase leads to 
phosphorylation of a trans-acting element, which 
in the phosphorylated form can induce transcrip- 
tion of the uPA gene. Thus, the rate of transcrip- 
tion of the uPA gene would be determined by the 
relative kinase and phosphatase activities, which 
determine the phosphorylation state of the trans- 
acting element. 
The mutants FIB4 and FIB6 appear to be af- 
fected specifically in C-subunit activity. they 
possess an apparent structural mutation in the C- 
subunit protein are present. The residual kinase 
present in FIB4 and FIB6 exhibits parental levels 
of activation by CAMP and normal affinities for 
substrates ATP and Kemptide, but has about 10% 
parental V,,,. In contrast, the ‘CAMP resistant’ 
mutants FIBl, FIB2 and FIB5 have only somewhat 
reduced C activity, and other data (Jans, D., 
Resink, T. and Hemmings, B., in preparation) 
show that they are affected in another component 
of CAMP metabolism, most probably adenylate 
cyclase . 
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